Trial intelligence / Profile preview

Influenza Vaccination in Plasma Cell Dyscrasias

NCT04080531Phase 4Completed

Sponsor
Emory University
Start
Oct 2019
Primary completion
May 2021
Modality
Vaccines & Immunotherapeutics
Countries
1
01

Overview

A Phase 4 trial of Fluzone Trivalent in influenza, sponsored by Emory University. Started Oct 2019; status: completed.

02

Drugs

Fluzone Trivalent
03

Conditions

influenza

Beyond the preview

Go deeper on NCT04080531.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04080531.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call